Are asset managers still good stocks to hold? This screen holds some clues

The article is a valuation-focused screen of 10 Canadian asset managers, comparing StockCalc intrinsic values with market prices using DCF, price comps, ABV, and analyst targets. It highlights consolidation in the sector and notes that Fiera Capital (FSZ-T) screens with upside, Cymbria (CYB-T) appears fairly valued, and Stack Capital (STCK-T) shows a large divergence between model value and analyst target. Overall, the piece is analytical rather than event-driven and is unlikely to move the broader market.

Analysis

The key signal is not valuation dispersion; it is business-model bifurcation. In a market that is rewarding product innovation and scale, the weakest franchises are those relying on sticky but low-growth AUM with limited pricing power, while the winners will be managers that can monetize illiquidity, private-market access, or embedded optionality in venture/growth assets. That makes capital-light public-market managers vulnerable to fee compression over the next 12-24 months if passive allocation continues to take share and if distribution costs rise faster than net inflows.

For STCK.TO specifically, the divergence between intrinsic and consensus value is usually a tell that the market is either paying for a funding/exit window or ignoring mark-to-market fragility. Venture and late-stage portfolios can look resilient until the first real test: fewer IPOs, wider private-market discounts, and down-round marks can hit NAV with a lag of 2-4 quarters, then show up abruptly in sentiment and financing terms. If public comps remain range-bound, the stock may lag not because the underlying assets are impaired immediately, but because the path to monetization is getting longer and the discount rate is rising.

The broader second-order effect is that consolidation pressure likely increases, but mostly on the weaker small- and mid-cap platforms. Larger managers with stronger balance sheets can use M&A to pick up distribution, seed capital, or alternative sleeves at depressed multiples, while smaller names face a choice between dilution, dividend cuts, or selling at book value. In that sense, the near-term upside in the group is less about aggregate sector re-rating and more about identifying which firms have enough fee resilience and balance-sheet flexibility to survive a slower exits cycle.

The contrarian angle is that private-markets exposure is currently being treated as a diversification premium, but it can quickly become an illiquidity discount if capital markets stay selective. If the IPO window does not reopen meaningfully in the next 6-9 months, managers with venture-heavy books will likely see model revisions before the market fully prices the slowdown. That creates a window where reported NAVs still look acceptable, while the equity has already started discounting lower realizable value.

Key Decisions for Investors

• Long STCK.TO only as a tactical event-driven position, sized small, with a 3-6 month horizon; use a tight stop if there is no improvement in public-market exit activity or if the stock fails to close the valuation gap after the next reporting cycle.
• Pair trade: long diversified, fee-stable asset manager exposure vs short a venture/private-markets-heavy name like STCK.TO over 6-12 months; the trade benefits from continued IPO scarcity and widening private-mark-to-market haircuts.
• Avoid chasing the highest headline discounts in the group; prefer firms with strong recurring fee mix and net cash, since they can protect dividends and use M&A opportunistically if sector multiples compress further.
• For opportunistic traders, buy puts or put spreads on STCK.TO into any strength tied to a broad risk-on tape; the risk/reward improves if the market is temporarily rewarding beta while fundamentals are still lagging.